Abstract:The tumor-suppressor protein p53 is tightly controlled in normal cells by its two negative regulators—the E3 ubiquitin ligase MDM2 and its homolog MDMX. Under stressed conditions such as DNA damage, p53 escapes MDM2- and MDMX-mediated functional inhibition and degradation, acting to prevent damaged cells from proliferating through induction of cell cycle arrest, DNA repair, senescence or apoptosis. Ample evidence suggests that stress signals induce phosphorylation of MDM2 and MDMX, leading to p53 activation. However, the structural basis of stress-induced p53 activation remains poorly understood because of the paucity of technical means to produce site-specifically phosphorylated MDM2 and MDMX proteins for biochemical and biophysical studies. Herein, we report total chemical synthesis, via native chemical ligation, and functional characterization of (24–108)MDMX and its Tyr99-phosphorylated analog with respect to their ability to interact with a panel of p53-derived peptide ligands and PMI, a p53-mimicking but more potent peptide antagonist of MDMX, using FP and surface plasmon resonance techniques. Phosphorylation of MDMX at Tyr99 weakens peptide binding by approximately two orders of magnitude. Comparative X-ray crystallographic analyses of MDMX and of pTyr99 MDMX in complex with PMI as well as modeling studies reveal that the phosphate group of pTyr99 imposes extensive steric clashes with the C-terminus of PMI or p53 peptide and induces a significant lateral shift of the peptide ligand, contributing to the dramatic decrease in the binding affinity of MDMX for p53. Because DNA damage activates c-Abl tyrosine kinase that phosphorylates MDMX at Tyr99, our findings afford a rare glimpse at the structural level of how stress-induced MDMX phosphorylation dislodges p53 from the inhibitory complex and activates it in response to DNA damage.

Regulation of MDM2 Stability After DNA Damage

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

The Regulation of MDM2 Oncogene and Its Impact on Human Cancers

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Interplay Between Mdm2 And Hipk2 In The Dna Damage Response

Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.

Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase

MDM2 Promotes Genome Instability by Ubiquitinating the Transcription Factor HBP1

Mdm2 links genotoxic stress and metabolism to p53

Interactions Between P53 And Mdm2 In A Mammalian-Cell Cycle Checkpoint Pathway

Stabilization of Mdm2 Via Decreased Ubiquitination is Mediated by Protein Kinase B/Akt-dependent Phosphorylation

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction

Structural basis of how stress-induced MDMX phosphorylation activates p53

Homeostatic Regulation of Base Excision Repair by A P53-Induced Phosphatase - Linking Stress Response Pathways with Dna Repair Proteins

Characterization of cancer-associated missense mutations in MDM2

Critical Role for Daxx in Regulating Mdm2

Small Molecule Agents Targeting the P53-Mdm2 Pathway for Cancer Therapy

Interrogation of MDM2 Phosphorylation in P53 Activation Using Native Chemical Ligation: the Functional Role of Ser17 Phosphorylation in MDM2 Reexamined

MDM2: current research status and prospects of tumor treatment

The Wip1 Phosphatase And Mdm2: Cracking The "Wip" On P53 Sta